Annual SG&A
$1.33 M
+$428.98 K+47.50%
30 September 2024
Summary:
Tekla Life Sciences Investors annual selling, general & administrative expenses is currently $1.33 million, with the most recent change of +$428.98 thousand (+47.50%) on 30 September 2024. During the last 3 years, it has risen by +$488.10 thousand (+57.83%). HQL annual SG&A is now at all-time high.HQL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
N/A
30 September 2024
Summary:
Tekla Life Sciences Investors quarterly selling, general & administrative expenses is not available.HQL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$74.32 M
+$45.61 M+158.86%
30 September 2024
Summary:
Tekla Life Sciences Investors TTM selling, general & administrative expenses is currently $74.32 million, with the most recent change of +$45.61 million (+158.86%) on 30 September 2024. HQL TTM SG&A is now -63.75% below its all-time high of $797.51 thousand, reached on 31 March 2020.HQL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HQL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.5% | - | - |
| 3 y3 years | +57.8% | - | - |
| 5 y5 years | - | - | +10000.0% |
HQL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +57.8% | -63.8% | +193.2% | ||
| 5 y | 5 years | at high | +57.8% | -63.8% | +193.2% | ||
| alltime | all time | at high | +57.8% | -63.8% | +193.2% |
Tekla Life Sciences Investors Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $1.33 M(+47.5%) | - | - |
| Sept 2023 | $903.14 K(-16.1%) | - | - |
| Sept 2022 | $1.08 M(+27.6%) | - | - |
| Sept 2021 | $844.02 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $375.89 K(-10.8%) | $797.51 K(+89.2%) |
| Sept 2019 | - | $421.62 K(>+9900.0%) | $421.62 K(+6.4%) |
| Mar 2019 | - | $0.00(-100.0%) | $396.20 K(0.0%) |
| Sept 2018 | - | $396.20 K | $396.20 K |
FAQ
- What is Tekla Life Sciences Investors annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual SG&A year-on-year change?
- What is the all time high quarterly SG&A for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tekla Life Sciences Investors?
What is Tekla Life Sciences Investors annual selling, general & administrative expenses?
The current annual SG&A of HQL is $1.33 M
What is the all time high annual SG&A for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual selling, general & administrative expenses is $1.33 M
What is Tekla Life Sciences Investors annual SG&A year-on-year change?
Over the past year, HQL annual selling, general & administrative expenses has changed by +$428.98 K (+47.50%)
What is the all time high quarterly SG&A for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly selling, general & administrative expenses is $421.62 K
What is Tekla Life Sciences Investors TTM selling, general & administrative expenses?
The current TTM SG&A of HQL is $74.32 M
What is the all time high TTM SG&A for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high TTM selling, general & administrative expenses is $797.51 K